EcoDrugPlus

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSSARG00000007365
Gene Symbol: SRD5A2
1 External references
263 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSSARG00000007306
Gene Symbol: TACR1
1 External references
267 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSSARG00000013271
Gene Symbol: TBXA2R
1 External references
192 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSSARG00000012400
Gene Symbol: TYMS
1 External references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSSARG00000013590
Gene Symbol: THRB
1 External references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSSARG00000006509
Gene Symbol: TRHR
1 External references
266 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSSARG00000002662
Gene Symbol: TLR2
1 External references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSSARG00000002362
Gene Symbol: TLR4
1 External references
127 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSSARG00000002691
Gene Symbol: TLR9
3 External references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSARG00000001694
Gene Symbol: TAAR1
3 External references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSSARG00000011844
Gene Symbol: TGFBR1
1 External references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSSARG00000009465
Gene Symbol: TRPA1
1 External references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).